HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Foëx Selected Research

Infarction (Infarctions)

9/2000Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels.
5/2000Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Foëx Research Topics

Disease

2Myocardial Infarction
12/2017 - 06/2004
2Infarction (Infarctions)
09/2000 - 05/2000
1Heart Failure
12/2017
1Cardiovascular Diseases (Cardiovascular Disease)
11/2005
1Myocardial Stunning (Stunned Myocardium)
08/2001
1Coronary Occlusion
09/2000

Drug/Important Bio-Agent (IBA)

2IsofluraneFDA LinkGeneric
08/2001 - 09/2000
1sacubitril and valsartan sodium hydrate drug combinationIBA
12/2017
1IvabradineIBA
12/2017
1TroponinIBA
12/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2005
1Adenosine (Adenocard)FDA LinkGeneric
08/2001
1GadoliniumIBA
09/2000
1ChloridesIBA
09/2000
15-hydroxydecanoic acidIBA
09/2000
1Coloring Agents (Dyes)IBA
09/2000
1triphenyltetrazoliumIBA
05/2000
1Protein Kinase CIBA
05/2000
1Fentanyl (Sublimaze)FDA LinkGeneric
05/2000
1delta Opioid Receptors (delta Opioid Receptor)IBA
05/2000

Therapy/Procedure

2Therapeutics
11/2005 - 06/2004
1Cardiac Resynchronization Therapy
12/2017